Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06359808
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2024-04-06
Brief Title:
Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis
Sponsor:
Xijing Hospital
Organization:
Xijing Hospital
Study Overview
Official Title:
A Study Based on the Microbiota-gut-brain Axis to Explore the Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Ulcerative colitisUC is one of the two main forms of inflammatory bowel diseaseIBD which seriously affects the quality of life of patients Previous studies have demonstrated that more than 60 of IBD patients have sleep disorders which is emerging as an important risk factor for disease recurrence and poor prognosis However the mechanisms by which sleep disorders regulates the occurrence and development of IBD remain undefined This study aims to explore the clinical characteristics of ulcerative colitis patients with sleep disorders based on the microbiota-gut-brain axis to analyze the effects of sleep disorders on autonomic nervous function gut microbiota and metabolites in UC patients
Detailed Description:
According to the inclusion and exclusion criteria 152 UC patients of the First Affiliated Hospital of the Air Forth Medical University from April 2024 to December 2024 will be included The PSQI scale was used to evaluate the sleep quality of the enrolled patients and the overall incidence and severity of sleep disorders in UC patients will be evaluated According to whether the PSQI score is higher than 5 points the subjects will be divided into UC with sleep disorder group and the UC without sleep disorder group By reviewing electronic medical records and questionnaire surveys general clinical information of the subjects will be collected to analyze the risk factors of sleep disorders in UC patients Mayo score and fecal calprotectin levels will be used to assess disease activity The correlation between sleep disorders and disease activity in UC patients will be evaluated Age- gender- and education level-matched healthy controls will be recruited from The First Affiliated Hospital of the Air Forth Medical University from April 2024 to December 2024 Heart rate variability will be measured to evaluate vagal nerve activity Serum pancreatic peptide norepinephrine acetylcholine and serotonin will be measured to evaluate serum neurotransmitter levels and resting state functional magnetic resonance imaging will be used to evaluate the brain functional activity area of the subjects Differences and correlations in autonomic nervous system function between UC with sleep disorder and UC without sleep disorder will be explored 16s sequencing and metabolomics will be used to analyze changes in gut microbiota and metabolites The correlation between gut microbiota and metabolites and sleep disorders in UC patients will be explored
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None